Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
923 studies found for:    Open Studies | "Carcinoma, Non-Small-Cell Lung"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma, Non-Small-Cell Lung"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Safety & Immunogenicity of JNJ-64041757, Live-attenuated Double-deleted Listeria Immunotherapy, in Subjects With Non Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Biological: JNJ-64041757 (Cohort 1A and 1B);   Biological: JNJ-64041757 (Cohort 2A and 2B)
2 Recruiting Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers
Condition: Carcinoma, Non-small Cell Lung
Interventions: Drug: Aprepitant;   Drug: placebo
3 Recruiting Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers
Condition: Carcinoma, Non-small Cell Lung
Intervention: Drug: ethaselen
4 Recruiting BIO 300 Non-Small Cell Lung Cancer Study
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: BIO 300 Oral Suspension;   Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Radiotherapy
5 Recruiting Effect of Genetic Polymorphisms on Platinum Based Chemotherapy in Non Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention:
6 Recruiting A Trial of AP32788 in Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: AP32788
7 Recruiting Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Procedure: sublobar resection;   Procedure: lobectomy
8 Recruiting Crizotinib in Pretreated Metastatic Non-small-cell Lung Cancer With MET Amplification or ROS1 Translocation (METROS)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Crizotinib
9 Recruiting Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage IB and II Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Durvalumab;   Other: Durvalumab plus SBRT
10 Recruiting Pemetrexed in Advanced Non-Small-Cell Lung Cancer: at Progression vs Maintenance Therapy After Induction Chemotherapy
Condition: Carcinoma, Non-small-cell Lung
Interventions: Drug: maintenance pemetrexed;   Drug: pemetrexed at progression
11 Recruiting A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Radiation: Response-driven Adaptive Radiation Therapy;   Drug: Carboplatin;   Drug: Paclitaxel;   Device: FDG-PET;   Device: V/Q SPECT
12 Recruiting Single Agent Versus Combination Chemotherapy to Treat High-risk Elderly With Non-small Cell Lung Cancer
Condition: Carcinoma, Non-small Cell Lung
Interventions: Drug: Carboplatin;   Drug: Nab-paclitaxel
13 Recruiting Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutation
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Afatinib
14 Not yet recruiting MK-3475 in Combination With Docetaxel vs Docetaxel Alone in Non-Small Cell Lung Cancer Patients
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: MK-3475;   Drug: Docetaxel
15 Recruiting Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: INC280 (capmatinib)
16 Recruiting Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Glesatinib;   Drug: Sitravatinib;   Drug: Mocetinostat;   Drug: Nivolumab
17 Recruiting Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small Cell Lung
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Drug: Bevacizumab;   Drug: Pemetrexed;   Drug: cisplatin
18 Recruiting Study of Pembrolizumab Versus Docetaxel in Participants Previously Treated for Non-Small Cell Lung Cancer (MK-3475-033)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Biological: pembrolizumab 2 mg/kg;   Drug: Docetaxel 75 mg/m^2
19 Recruiting BI 836845 Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: BI 836845;   Drug: afatinib
20 Not yet recruiting Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Vinblastine Sulfate;   Radiation: three dimensional conformal radiotherapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.